Loading viewer...
investor_presentation
Format: PDF investor_presentation
Myokardia management presentation from March 2017 outlining clinical development programs for MYK-461 and MYK-491, advancing precision cardiovascular medicine. The presentation discusses the Phase 2 PIONEER-HCM trial and collaboration with Sanofi to develop novel therapies for serious cardiovascular disease.
presentation
investor_presentation
37 Pages
Trex Company